BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32839414)

  • 1. Roles of Cannabinoids in Melanoma: Evidence from In Vivo Studies.
    Bachari A; Piva TJ; Salami SA; Jamshidi N; Mantri N
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32839414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabinoids and their derivatives in struggle against melanoma.
    Marzęda P; Drozd M; Wróblewska-Łuczka P; Łuszczki JJ
    Pharmacol Rep; 2021 Dec; 73(6):1485-1496. PubMed ID: 34264513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabinoids and Prostate Cancer: A Systematic Review of Animal Studies.
    Singh K; Jamshidi N; Zomer R; Piva TJ; Mantri N
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic inhibitory effects of Celecoxib and Plumbagin on melanoma tumor growth.
    Gowda R; Sharma A; Robertson GP
    Cancer Lett; 2017 Jan; 385():243-250. PubMed ID: 27769779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of Tanshinone II a inhibits malignant melanoma development through blocking autophagy signal transduction in A375 cell.
    Li X; Li Z; Li X; Liu B; Liu Z
    BMC Cancer; 2017 May; 17(1):357. PubMed ID: 28532456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting cannabinoid-induced cytotoxic autophagy to drive melanoma cell death.
    Armstrong JL; Hill DS; McKee CS; Hernandez-Tiedra S; Lorente M; Lopez-Valero I; Eleni Anagnostou M; Babatunde F; Corazzari M; Redfern CPF; Velasco G; Lovat PE
    J Invest Dermatol; 2015 Jun; 135(6):1629-1637. PubMed ID: 25674907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natural Compounds in the Chemoprevention of Malignant Melanoma.
    Danciu C; Soica C; Antal D; Alexa E; Pavel IZ; Ghiulai R; Ardelean F; Babuta RM; Popescu A; Dehelean CA
    Anticancer Agents Med Chem; 2018; 18(5):631-644. PubMed ID: 29173184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Casticin Induced Apoptosis in A375.S2 Human Melanoma Cells through the Inhibition of NF-[Formula: see text]B and Mitochondria-Dependent Pathways In Vitro and Inhibited Human Melanoma Xenografts in a Mouse Model In Vivo.
    Shiue YW; Lu CC; Hsiao YP; Liao CL; Lin JP; Lai KC; Yu CC; Huang YP; Ho HC; Chung JG
    Am J Chin Med; 2016; 44(3):637-61. PubMed ID: 27109154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma.
    Momtaz S; Niaz K; Maqbool F; Abdollahi M; Rastrelli L; Nabavi SM
    Biofactors; 2017 May; 43(3):347-370. PubMed ID: 27896891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Cannabinoids on Pro- and Anti-Inflammatory Cytokines: A Systematic Review of
    Henshaw FR; Dewsbury LS; Lim CK; Steiner GZ
    Cannabis Cannabinoid Res; 2021 Jun; 6(3):177-195. PubMed ID: 33998900
    [No Abstract]   [Full Text] [Related]  

  • 11. The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids.
    McAllister SD; Soroceanu L; Desprez PY
    J Neuroimmune Pharmacol; 2015 Jun; 10(2):255-67. PubMed ID: 25916739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (S)-(-)-N-[2-(3-Hydroxy-2-oxo-2,3-dihydro-1H-indol-3-yl)-ethyl]-acetamide inhibits melanoma cell growth through inducing apoptosis and autophagy.
    Wang D; Li Q; Wang Y; Jiang Y
    Cutan Ocul Toxicol; 2021 Dec; 40(4):293-299. PubMed ID: 33287574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-THC cannabinoids inhibit prostate carcinoma growth in vitro and in vivo: pro-apoptotic effects and underlying mechanisms.
    De Petrocellis L; Ligresti A; Schiano Moriello A; Iappelli M; Verde R; Stott CG; Cristino L; Orlando P; Di Marzo V
    Br J Pharmacol; 2013 Jan; 168(1):79-102. PubMed ID: 22594963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential role of cannabinoids in the pathogenesis of skin cancer.
    Glodde N; Jakobs M; Bald T; Tüting T; Gaffal E
    Life Sci; 2015 Oct; 138():35-40. PubMed ID: 25921771
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Emhemmed F; Zhao M; Yorulmaz S; Steyer D; Leitao C; Alignan M; Cerny M; Paillard A; Delacourt FM; Julien-David D; Muller CD
    Molecules; 2022 Feb; 27(4):. PubMed ID: 35209003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical study of the medicinal plants for the treatment of malignant melanoma.
    Aydoğmuş-Öztürk F; Jahan H; Öztürk M; Günaydın K; Choudhary MI
    Mol Biol Rep; 2020 Aug; 47(8):5975-5983. PubMed ID: 32710386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Plant Sesquiterpene Lactone Derivative, DETD-35, Suppresses BRAFV600E Mutant Melanoma Growth and Overcomes Acquired Vemurafenib Resistance in Mice.
    Feng JH; Nakagawa-Goto K; Lee KH; Shyur LF
    Mol Cancer Ther; 2016 Jun; 15(6):1163-76. PubMed ID: 27048951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downregulation of tumor growth and invasion by redox-active nanoparticles.
    Alili L; Sack M; von Montfort C; Giri S; Das S; Carroll KS; Zanger K; Seal S; Brenneisen P
    Antioxid Redox Signal; 2013 Sep; 19(8):765-78. PubMed ID: 23198807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cannabinoids in the treatment of cancer.
    Alexander A; Smith PF; Rosengren RJ
    Cancer Lett; 2009 Nov; 285(1):6-12. PubMed ID: 19442435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of plant cannabinoids with emphasis on the effect of cannabidiol on human breast carcinoma.
    Ligresti A; Moriello AS; Starowicz K; Matias I; Pisanti S; De Petrocellis L; Laezza C; Portella G; Bifulco M; Di Marzo V
    J Pharmacol Exp Ther; 2006 Sep; 318(3):1375-87. PubMed ID: 16728591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.